Altered retinal MicroRNA expression profiles in early diabetic retinopathy: An in silico analysis

Current Eye Research

Volumn 39, Issue 7, 2014, Pages 720-729

  Xiong, Fen ^a   Du, Xinhua ^a   Hu, Jianyan ^a   Li, Tingting ^a   Du, Shanshan ^a   Wu, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bioinformatics; Diabetic retinopathy; GO analysis; MicroRNA; Pathway analysis

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; INOSITOL PHOSPHATE; MICRORNA; MICRORNA 137 5P; MICRORNA 203A 3P; MICRORNA 212 3P; MICRORNA 216A 5P; MICRORNA 219 1 3P; MICRORNA 24 1 5P; MICRORNA 323 3P; MICRORNA 34C 5P; MICRORNA 350; MICRORNA 351 5P; MICRORNA 369 5P; MICRORNA 375 3P; MICRORNA 410 3P; MICRORNA 592; MICRORNA 758 3P; MICRORNA 92A 1 5P; MICRORNA 935; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL; RNA POLYMERASE II; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL CYCLE; COMPARATIVE STUDY; COMPUTER MODEL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOWN REGULATION; EXCISION REPAIR; GENE EXPRESSION; GENE FUNCTION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENE TARGETING; MALE; MICROARRAY ANALYSIS; NERVE FIBER; NONHUMAN; OLFACTORY BULB; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIGHT JUNCTION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; BIOSYNTHESIS; COMPUTER SIMULATION; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REPRODUCIBILITY; TIME;

ANIMALS; COMPUTER SIMULATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICRORNAS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RETINA; TIME FACTORS;

EID: 84901822422     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.872280     Document Type: Article

References (42)

1. Gargiulo P, Giusti C, Pietrobono D, La Torre D, Diacono D, Tamburrano G. Diabetes mellitus and retinopathy. Dig Liver Dis 2004;36:S101-S105.
2. Joussen AM, Huang S, Poulaki V, Camphausen K, Beecken WD, Kirchhof B, et al. In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci 2001;42: 3047-3057.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
4. van Rooij E. The art of microRNA research. Circ Res 2011; 108:219-234.
5. Natarajan R, Putta S, Kato M. MicroRNAs and diabetic complications. J Cardiovasc Transl Res 2012;5:413-422.
6. Bai Y, Bai X, Wang Z, Zhang X, Ruan C, Miao J. MicroRNA- 126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp Mol Pathol 2011;91:471-477.
7. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011;60:1314-1323.
8. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, et al. MicroRNAs regulate ocular neovascularization. Mol Ther 2008;16:1208-1216.
9. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006;55:2401-2411.
10. Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2011;52:4402-4409.
11. Silva VA, Polesskaya A, Sousa TA, Correa VM, Andre ND, Reis RI, et al. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNAdependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol Vis 2011;17:2228-2240.
12. Shalgi R, Lieber D, Oren M, Pilpel Y. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 2007;3:e131.
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25-29.
14. The Gene Ontology (GO) project in 2006. Nucleic Acids Res 2006;34:D322-D326.
15. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, et al. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 2007;25:663-668.
16. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004;32:D277-D280.
17. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. WholePathwayScope: a comprehensive pathwaybased analysis tool for high-throughput data. BMC Bioinformatics 2006;7:30.
18. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, et al. A systems biology approach for pathway level analysis. Genome Res 2007;17:1537-1545.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25: 402-408.
20. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003;19:2448-2455.
21. Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW. Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 2005;22: 593-603.
22. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 2008;8:37-49.
23. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007;26:731-743.
24. Wu JH, Gao Y, Ren AJ, Zhao SH, Zhong M, Peng YJ, et al. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic Res 2012;47:195-201.
25. Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 2013;10:93-113.
26. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 2009; 106:5813-5818.
27. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003;46: 1260-1268.
28. Miyahara S, Kiryu J, Yamashiro K, Miyamoto K, Hirose F, Tamura H, et al. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. Am J Pathol 2004;164: 1697-1706.
29. Sandvig I, Thuen M, Hoang L, Olsen O, Sardella TC, Brekken C, et al. In vivo MRI of olfactory ensheathing cell grafts and regenerating axons in transplant mediated repair of the adult rat optic nerve. NMR Biomed 2012;25: 620-631.
30. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791.
31. Hu J, Wu Q, Li T, Chen Y, Wang S. Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91. Exp Eye Res 2013;109:31-39.
32. Rajala RV. Phospho-site-specific antibody microarray to study the state of protein phosphorylation in the retina. J Proteomics Bioinform 2008;1:242-250.
33. Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1995;1:527-534.
34. Quin G, Len AC, Billson FA, Gillies MC. Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 2007;7:2636-2650.
35. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol 2002;46:249-253.
36. Yingchuan F, Chuntao L, Hui C, Jianbin H. Increased expression of TGF-beta1 and Smad 4 on oxygen-induced retinopathy in neonatal mice. Adv Exp Med Biol 2010;664: 71-77.
37. Du W, Yu W, Huang L, Zhao M, Li X. Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway. Invest Ophthalmol Vis Sci 2012;53: 1990-1998.
38. Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, Aoki M, et al. Phosphorylation of p38 mitogen-activated protein kinase downstream of baxcaspase- 3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 2001;50: 1472-1481.
39. Zhan Y, Gong K, Chen C, Wang H, Li W. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells. Free Radic Biol Med 2012;53:532-543.
40. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
41. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006;126:1203-1217.
42. Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007;59:75-86.